Biocompatible Nanoparticle Technology Being Used to Develop Cancer Therapies & Rapid Diagnostics

Sona’s unique gold nanorods have the potential to power the next generation of lateral flow diagnostics and play a key role in the advancement of impactful scientific and medical applications

Available for Mac, Windows, Chrome, and iOS.


Trusted by global brands

Upcoming Webinars

Medical Webinar

Sun, Apr 21st 2024 1pm EDT

This webinar will focus on the therapy’s scientific premises and pre-clinical interim study data results, as well as the clinical potential of using Sona’s nanotechnology to shrink tumors and better enable immunotherapies.

Investor Webinar

Mon, Apr 22nd 2024 1pm EDT

This webinar will focus on providing an overview of Sona’s Targeted Hyperthermia Therapy, its preclinical development path and its market potential.

Recent Webinars


Sona Gold Nanorod ("GNR") Technology 

Uniquely biocompatible.
Unlocking of in-vivo medical applications potential



Targeted Hyperthermia Therapy

Sona GNRs in targeted hyperthermia may create the
opportunity to treat cancer without doing significant harm to healthy cells.

Concussion Tests

Sona’s concussion screening test to be used at the scene of injury

Bovine Tuberculosis Tests

Early detection at low cost without the need for test-and-slaughter

Latest News Releases

Market Coverage Report

Report by:


Varius nisi aliquet at nisi augue tempus. Eu vitae maecenas tellus varius quis pretium. Amet nibh venenatis nunc feugiat lectus.

Subscribe to Our Newsletter

Download the Company Presentation

Read or Download the Latest White Paper

The Case for Hyperthermia Thermal Therapy for Cancer - White Paper - Sona Nanotech

The Case for “Hyperthermia” Thermal Therapy for Cancer